Clinical Trial Update: The Effect of Green Tea Extract on Type 2 Diabetes With Hyperlipidemia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating green tea extract for people with type 2 diabetes and hyperlipidemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia
• Type 2 Diabetes Mellitus

Drugs mentioned

• Green Tea Extract (Camellia sinensis extract)

Snippet

Sponsor: Taipei City Hospital | Conditions: Type 2 Diabetes, Hyperlipidemia | Phase 3 | Status: COMPLETED